End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,880 KRW | +0.70% | +6.88% | +3.41% |
04-05 | Enzychem Lifesciences Corporation announces an Equity Buyback for KRW 10,000 million worth of its shares. | CI |
04-05 | Enzychem Lifesciences Corporation authorizes a Buyback Plan. | CI |
Sales 2022 | 26.64B 19.37M 26.45M | Sales 2023 | 76.04B 55.28M 75.51M | Capitalization | 155B 112M 154M |
---|---|---|---|---|---|
Net income 2022 | -25.09B -18.24M -24.92M | Net income 2023 | -9.33B -6.78M -9.26M | EV / Sales 2022 | -0.58 x |
Net cash position 2022 | 155B 113M 154M | Net cash position 2023 | 132B 95.74M 131M | EV / Sales 2023 | 0.3 x |
P/E ratio 2022 |
-5.24
x | P/E ratio 2023 |
-16.5
x | Employees | 113 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.68% |
1 day | +0.70% | ||
1 week | +6.88% | ||
Current month | -0.16% | ||
1 month | -7.16% | ||
3 months | +9.81% | ||
6 months | +66.22% | ||
Current year | +3.41% |
Managers | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 16-10-20 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Hye-Kyung Kim
BRD | Director/Board Member | 66 | 12-06-30 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 11-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1,880 | +0.70% | 242,198 |
24-04-25 | 1,867 | -0.05% | 367,579 |
24-04-24 | 1,868 | +0.97% | 415,059 |
24-04-23 | 1,850 | +3.35% | 556,693 |
24-04-22 | 1,790 | +1.76% | 365,796 |
End-of-day quote Korea S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.41% | 116M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A183490 Stock